GGrantIndex
Sort

78,016 grants matching breast cancer

CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS

$665,514
Stephen J Lippard · Massachusetts Institute Of Technology · R37 · FY2007 · CA

Cbl Proteins as Regulators of Tyrosine Kinase Signaling

$665,492
Stanley Lipkowitz · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

PDX Core

$665,485
Shunqiang Li · Washington University · U54 · FY2017 · CA

Impact of enhancements to smartphone-based continuing care for alcohol dependence

$665,403
James R McKay · University Of Pennsylvania · R01 · FY2017 · AA

Weight management and Black American women: Targeting social networks as a strategy to improve outcomes

$665,368
Marian L Fitzgibbon · University Of Illinois At Chicago · R01 · FY2025 · CA

Clinical decision-support algorithms for interactive design of patient-specific breast molds

$665,331
Fatima A Merchant · University Of Houston · R01 · FY2024 · CA

Washington University Co-Clinical Imaging Research Resource

$665,295
Kooresh Isaac Shoghi · Washington University · U24 · FY2022 · CA

Defining brain-body feedback loops mediating stress-induced metastasis

$665,155
Mikala Egeblad · Johns Hopkins University · U01 · FY2024 · CA

Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens

$665,035
Donald P McDonnell · Duke University · R01 · FY2022 · CA

Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health

$665,018
Guy H Montgomery · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

The role of TRIM37 in driving tumorigenesis and cancer-specific vulnerability to PLK4 inhibition

$664,969
Sergi Regot · Johns Hopkins University · R01 · FY2022 · CA

Lymphedema therapy via lymphatic targeted drug delivery

$664,892
Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2024 · HL

Developing a novel combination immunotherapy for triple-negative breast cancer

$664,874
Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2023 · CA

Breast Cancer and the Environment Research Center

$664,865
Sandra Z Haslam · Michigan State University · U01 · FY2007 · ES

Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer

$664,854
Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · DE

Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer

$664,828
Neil Mukund Iyengar · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM

$664,826
Luis Baez · Municipio De San Juan · U10 · FY2006 · CA

MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)

$664,819
Harold L Moses · Vanderbilt University · U54 · FY2015 · CA

THE AUSTRALIAN BREAST CANCER FAMILY REGISTRY

$664,818
University Of Melbourne · U01 · FY2005 · CA

Physiological and pathological functions of E3 ubiquitin ligases Smurfs

$664,812
Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL

$664,703
Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2015 · CA

Clinical Onology Program Biostatistical Center

$664,660
University Of Pittsburgh At Pittsburgh · U10 · FY2002 · CA

Probiotic guided CAR-T therapy (ProCARs) for breast cancer

$664,480
Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · EB

Precision Genomics in the WISDOM Pragmatic Clinical Trial: An "Embedded" ELSI Study of Risk-based Breast Cancer Screening

$664,427
Barbara A. Koenig · University Of California, San Francisco · R01 · FY2017 · CA

Outreach Core

$664,420
Angela M Pattatucci · University Of Tx Md Anderson Can Ctr · U54 · FY2016 · CA